Posted By Simon Montford on March 3, 2015
Quell is the only drug-free FDA approved, and doctor recommended, device in the States that's clinically proven to relieve chronic pain at the touch of a button. The Boston-based company wants to help millions of people avoid discomfort as well as the health implications, and side-effects of taking pain-relieving medication. NeuroMetrix, Quell's creator, launched a crowdfunding campaign on Indiegogo earlier this week that exceeded its funding target a day after launch.
According to the company's Indiegogo campaign page, it works by stimulating sensory nerves that cause the brain to send out pain-blocking neural pulses throughout the body. Quell comes with an app that enables the wearer to automatically track and personalize their pain therapy.
Once an electrode is attached to Quell it is placed inside a sport band, and worn around the upper calf. The electrode is in direct contact with the skin, where it goes to work sending neural pulses to the brain which then stimulates the body's natural pain relief response.
According to Wikipedia, over 100 million Americans suffer from chronic pain, and according to Pain UK, 2.6 million Brits are affected. This cost the British tax payer £6.7 billion last year (not to mention the economic impact of the 4.2% of the working population who were prevented from doing so due to immobility).
Demand exceeded the company's expectations, after the initial batch of pre-orders sold out in less than six hours. The special offer price of $199 (£130) has, however, been extended for another 48hrs. The estimated shipping date is June 2015, but please not this product is only available to US residents. We have contacted NeuroMetrix to find out if and when it will become available to UK citizens, and will add their response to the comments below when we hear back from them.
Subscribe to our newsletter and you’ll receive product updates as well as the latest IOT news delivered straight to your inbox.
© Simon Montford (WEB3IOT), 2014-2019. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Simon Montford and WEB3IOT with appropriate and specific direction to the original content at web3iot.com.